Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial

Future Oncology, Ahead of Print.

Source: Future Oncology - June 24, 2020 Category: Cancer & Oncology Authors: Shalini Makawita Ghassan K  Abou-Alfa Sameek Roychowdhury Saeed Sadeghi Ivan Borbath Lipika Goyal Allen Cohn Angela Lamarca Do-Youn Oh Teresa Macarulla Rachna T  Shroff Michael Howland Ai Li Terry Cho Amit Pande Milind Javle Source Type: research